ENLV logo

Enlivex Therapeutics (ENLV) Return On Assets

Annual ROA

-78.92%
-33.00%-71.86%

31 December 2023

ENLV ROA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly ROA

-60.78%
+1.16%+1.87%

30 June 2024

ENLV Quarterly ROA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENLV ROA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-71.9%-27.3%
3 y3 years-169.3%-221.3%
5 y5 years-105.3%-31.5%

ENLV ROA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-418.9%at low-303.9%+1.9%
5 y5 years-418.9%at low-303.9%+1.9%
alltimeall time-418.9%+78.9%-853.2%+89.4%

Enlivex Therapeutics ROA History

DateAnnualQuarterly
June 2024
-
-60.78%(-1.9%)
Mar 2024
-
-61.94%(+4.8%)
Dec 2023
-78.92%(+71.9%)
-59.08%(+23.8%)
Sept 2023
-
-47.73%(+12.1%)
June 2023
-
-42.56%(-1.8%)
Mar 2023
-
-43.33%(+6.7%)
Dec 2022
-45.92%(+201.9%)
-40.60%(+18.3%)
Sept 2022
-
-34.31%(+17.2%)
June 2022
-
-29.28%(+41.6%)
Mar 2022
-
-20.68%(+37.4%)
Dec 2021
-15.21%(-48.1%)
-15.05%(-20.5%)
Sept 2021
-
-18.92%(-12.4%)
June 2021
-
-21.59%(-22.2%)
Mar 2021
-
-27.75%(-13.8%)
Dec 2020
-29.30%(-45.2%)
-32.21%(+13.1%)
Sept 2020
-
-28.47%(-14.0%)
June 2020
-
-33.11%(+4.9%)
Mar 2020
-
-31.55%(-35.6%)
Dec 2019
-53.44%(+39.0%)
-48.97%(+6.0%)
Sept 2019
-
-46.21%(+15.1%)
June 2019
-
-40.15%(-27.7%)
Mar 2019
-
-55.53%(-16.6%)
DateAnnualQuarterly
Dec 2018
-38.44%(-44.4%)
-66.62%(-925.5%)
Sept 2018
-
8.07%(+5.1%)
June 2018
-
7.68%(-140.1%)
Mar 2018
-
-19.14%(-59.3%)
Dec 2017
-69.11%(-54.1%)
-46.99%(-60.6%)
Sept 2017
-
-119.37%(-7.4%)
June 2017
-
-128.86%(+11.6%)
Mar 2017
-
-115.48%(+14.3%)
Dec 2016
-150.72%(+101.3%)
-101.03%(+4.2%)
Sept 2016
-
-96.99%(+22.1%)
June 2016
-
-79.45%(+11.9%)
Mar 2016
-
-71.03%(+16.9%)
Dec 2015
-74.89%(+251.4%)
-60.74%(+26.0%)
Sept 2015
-
-48.19%(+22.2%)
June 2015
-
-39.43%(+3.8%)
Mar 2015
-
-38.00%(+29.9%)
Dec 2014
-21.31%(-94.3%)
-29.25%(-17.4%)
Sept 2014
-
-35.42%(-68.7%)
June 2014
-
-113.27%(-80.2%)
Mar 2014
-
-572.55%(+58.3%)
Dec 2013
-374.18%(+154.9%)
-361.76%
Dec 2012
-146.79%
-

FAQ

  • What is Enlivex Therapeutics annual return on assets?
  • What is the all time high annual ROA for Enlivex Therapeutics?
  • What is Enlivex Therapeutics annual ROA year-on-year change?
  • What is Enlivex Therapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Enlivex Therapeutics?
  • What is Enlivex Therapeutics quarterly ROA year-on-year change?

What is Enlivex Therapeutics annual return on assets?

The current annual ROA of ENLV is -78.92%

What is the all time high annual ROA for Enlivex Therapeutics?

Enlivex Therapeutics all-time high annual return on assets is -15.21%

What is Enlivex Therapeutics annual ROA year-on-year change?

Over the past year, ENLV annual return on assets has changed by -33.00% (-71.86%)

What is Enlivex Therapeutics quarterly return on assets?

The current quarterly ROA of ENLV is -60.78%

What is the all time high quarterly ROA for Enlivex Therapeutics?

Enlivex Therapeutics all-time high quarterly return on assets is 8.07%

What is Enlivex Therapeutics quarterly ROA year-on-year change?

Over the past year, ENLV quarterly return on assets has changed by -13.05% (-27.34%)